Same performance of exome sequencing before and after fetal autopsy for congenital abnormalities: toward a paradigm shift in prenatal diagnosis?

Eur J Hum Genet. 2022 Aug;30(8):967-975. doi: 10.1038/s41431-022-01117-7. Epub 2022 May 16.

Abstract

Prenatal exome sequencing could be complex because of limited phenotypical data compared to postnatal/portmortem phenotype in fetuses affected by multiple congenital abnormalities (MCA). Here, we investigated limits of prenatal phenotype for ES interpretation thanks to a blindly reanalysis of postmortem ES data using prenatal data only in fetuses affected by MCA and harboring a (likely)pathogenic variant or a variant of unknown significance (VUS). Prenatal ES identified all causative variant previously reported by postmortem ES (22/24 (92%) and 2/24 (8%) using solo-ES and trio-ES respectively). Prenatal ES identified 5 VUS (in four fetuses). Two of them have been previously reported by postmortem ES. Prenatal ES were negative for four fetuses for which a VUS were diagnosed after autopsy. Our study suggests that prenatal phenotype is not a limitation for implementing pES in the prenatal assessment of unsolved MCA to personalize fetal medicine and could influence indication of postmortem examination.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abnormalities, Multiple* / genetics
  • Autopsy
  • Congenital Abnormalities* / diagnosis
  • Congenital Abnormalities* / genetics
  • Congenital Abnormalities* / pathology
  • Exome / genetics
  • Exome Sequencing
  • Female
  • Fetus / abnormalities
  • Humans
  • Pregnancy
  • Prenatal Diagnosis
  • Ultrasonography, Prenatal